1.Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future.
Clinical and Molecular Hepatology 2015;21(4):344-348
Transarterial chemoembolization (TACE) using doxorubicin-eluting beads (DEBs) have been introduced as a novel device which ensures more sustained and tumor-selective drug delivery and permanent embolization compared to conventional TACE with lipiodol. Studies highlighting the use of TACE with DEBs for the treatment of hepatocellular carcinoma (HCC) have shown similar or better results compared to conventional TACE with lipiodol. TACE with DEBs is increasingly being performed interchangeably with conventional TACE. This review assessed the characteristics, clinical outcomes and future direction of TACE with DEBs compared to conventional TACE.
Antineoplastic Agents/administration & dosage/chemistry
;
Carcinoma, Hepatocellular/*therapy
;
Chemoembolization, Therapeutic
;
Drug-Eluting Stents
;
Ethiodized Oil/chemistry
;
Humans
;
Liver Neoplasms/*therapy
2.Transcatheter Arterial Embolization of Renal VX-2 Carcinoma: Ethiodol-Ethanol Capillary Embolization Combined with Carboplatin.
Andras KONYA ; Byung Gil CHOI ; Carolyn S VAN PELT ; Kenneth C WRIGHT
Korean Journal of Radiology 2007;8(2):136-147
OBJECTIVE: We wanted to determine whether transcatheter Ethiodol-based capillary embolization in combination with carboplatin could improve the efficiency of a 1:1 Ethiodol-ethanol mixture (EEM) to ablate kidneys that been inoculated with VX-2 carcinoma. MATERIALS AND METHODS: The right kidney in 34 New Zealand white rabbits were inoculated with fresh VX-2 tumor fragments. One week later, the kidneys were subjected to transarterial treatment (4-5 rabbits/group): Saline infusion (Group 1); carboplatin infusion (5 or 10 mg, Groups 2A and 2B); carboplatin-Ethiodol (CE) alone (Group 3) and followed by main renal artery occlusion with ethanol (RAO) (Group 4); carboplatin-EEM (C-EEM) followed by RAO (Group 5); carboplatin infusion followed by EEM plus RAO (Group 6); and EEM followed by RAO (Group 7). The animals were followed for up to 3-weeks. The treated kidneys were evaluated angiographically and macroscopically. The kidneys that showed successful embolization macroscopically were entirely cut into serial sections, and these were examined microscopically. Histologically, the kidneys were evaluated on the basis of the residual tumor found in the serial sections. RESULTS: The results obtained with carboplatin infusion alone (Groups 2A and 2B) and CE without RAO (Group 3) were similar to those of the control animals (Group 1). Kidneys from Groups 4-7 demonstrated macroscopically successful embolization with histologically proven complete renal parenchyma infarction; however, some residual tumor was evident in all but one animal. CONCLUSION: None of the Ethiodol-based modalities combined with locoregional carboplatin were more efficacious for tumor ablation than EEM alone.
Angiography
;
Animals
;
Carboplatin/*administration & dosage
;
Chemoembolization, Therapeutic/*methods
;
Ethanol/*administration & dosage
;
Ethiodized Oil/*administration & dosage
;
Injections, Intra-Arterial
;
Kidney Neoplasms/*therapy
;
Rabbits
;
Statistics, Nonparametric
3.Percutaneous intratumoral injection with pingyangmycin lipiodol emulsion for treatment of recurrent sacrococcygeal chordomas.
Jing-yue GUAN ; Bei-bei WANG ; Chuan-jun WEI ; Yan-hao LI
Journal of Southern Medical University 2010;30(10):2366-2369
OBJECTIVETo evaluate the effectiveness and safety of fluoroscopy-guided percutaneous intratumor injection of pingyangmycin lipiodol emulsion (PLE) in the management of recurrent sacrococcygeal chordomas.
METHODSSeven patients with recurrent sacrococcygeal chordomas presenting with severe local pain with visual analogue score (VAS)≥8 received treatment sessions of fluoroscopy-guided percutaneous intratumor injection of PLE. The patients were followed up every 3 months after the last session to assess their clinical responses and observe the changes in the tumor size measured by computed tomography. The changes in the VAS, tumor necrosis and pain relief as well as the adverse events were recorded.
RESULTSA total of 22 sessions of fluoroscopy-guided percutaneous intratumoral PLE injection was performed in these cases (3 or 4 sessions in each case). The total average pingyangmycin dose delivered was 48.0 mg and the average lipiodol dose was 40.0 ml in each case. Five patients showed low fever and vomiting 48 after the injection. During the follow-up (median time of 21.7 months, range 10-26 months), all the patients showed obviously reduced tumor size and VAS, and partial remission was achieved in 6 patients and stable disease (SD) in 1 patient. None of the patients had complications during the follow-up.
CONCLUSIONFluoroscopy-guided percutaneous intratumoral injection of PLE can be effective and safe and may serve as a alternative for treatment of recurrent sacrococcygeal chordomas.
Adult ; Aged ; Bleomycin ; administration & dosage ; analogs & derivatives ; therapeutic use ; Chordoma ; drug therapy ; Emulsions ; administration & dosage ; therapeutic use ; Ethiodized Oil ; administration & dosage ; therapeutic use ; Female ; Humans ; Injections, Intralesional ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; drug therapy ; Sacrococcygeal Region ; pathology
4.Image-Guided Percutaneous Lipiodol-Pingyangmycin Suspension Injection Therapy for Sacral Chordoma.
Dexiao HUANG ; Yong CHEN ; Qingle ZENG ; Renhua WU ; Yanhao LI
Korean Journal of Radiology 2013;14(5):823-828
A 74-year-old man presented with a progressively worsening pain in sacrum and was diagnosed to have a sacral chordoma by biopsy in May, 2004. Percutaneous intratumoral injection with lipiodol-pingyangmycin suspension (LPS) was carried out under image guidance and repeated when the pain in sacrum recurred and the tumor increased. During a 6-year follow-up period, three sessions of this treatment were executed. CT imaging and Karnofsky Performance Score were used to evaluate the size of tumor and quality of life, respectively. The patient was free of pain after each procedure and had a high quality of life with a Karnofsky Performance Score above 80 points. The tumor lesion in sacral area was effectively controlled. No complications were observed. Percutaneous intratumoral injection with LPS under image guidance may be an effective and safe alternative for the patients with sacral chordoma.
Aged
;
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
;
Biopsy
;
Bleomycin/administration & dosage/analogs & derivatives
;
Chordoma/diagnosis/*drug therapy
;
Ethiodized Oil/administration & dosage
;
Humans
;
Injections, Intralesional
;
Magnetic Resonance Imaging
;
Male
;
*Sacrum
;
Spinal Neoplasms/diagnosis/*drug therapy
;
Suspensions
;
Tomography, X-Ray Computed
5.Changes of immune function in liver cancer patients after transcatheter arterial chemoembolizaton combined with interstitial therapy.
Yi QUAN ; Jian-Gang LIU ; Yue-Cheng CAI ; Ji-Ren ZHANG
Journal of Southern Medical University 2009;29(11):2288-2290
OBJECTIVETo study the changes of immune function in patients with liver cancer after transcatheter arterial chemoembolizaton (TACE) combined with interstitial therapy.
METHODSForty patients with liver cancer were randomly divided into groups A and B to received TACE and TACE combined with percutaneous lipiodol and anti-cancer agent injection into the tumor. The T lymphocyte cell subsets in the peripheral blood before and one week after the operation were measured by flow cytometry, and the immunoglobulin contents determined by single radial immunodiffusion.
RESULTSCD3, CD4, and CD4/8 levels increased significantly after the operation in both groups A and B (P<0.05). The postoperative CD3 and CD4 levels, but not that of CD8, differed significantly between the two groups (P<0.05). The operations also resulted in an increase in the contents of the immunoglobulins and complements in the two groups, but the changes were not significant in group A (P>0.05); in group B, significant increases occurred in the immunoglobulin and complement levels (P<0.05) with the exception of C3.
CONCLUSIONThe combination of TACE and interstitial therapy with percutaneous intratumor injections of lipiodol and anti-cancer agents may better improve the cell-mediated immunity and humoral immune function of liver cancer patients.
Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols ; administration & dosage ; Carcinoma, Hepatocellular ; drug therapy ; immunology ; Chemoembolization, Therapeutic ; methods ; Ethiodized Oil ; administration & dosage ; Female ; Humans ; Immunoglobulins ; blood ; Injections, Intralesional ; Liver Neoplasms ; drug therapy ; immunology ; Male ; Middle Aged ; T-Lymphocyte Subsets ; immunology
6.Value of mixed embolus transarterial chemoembolization in the treatment of hepatocellular carcinoma.
Chen-rui LI ; Wen-hao JIANG ; Xian-ming FENG ; Yan-jun GUO ; Zhong-hua SHI ; Chun-wu ZHOU
Chinese Journal of Oncology 2005;27(9):557-560
OBJECTIVETo investigate the value of transarterial chemoembolization (TACE) using mixed emboli for hepatocellular carcinoma (HCC).
METHODS188 patients with HCC were divided into two groups according to the treatment modality: 103 patients in group A treated by routine iodine embolus agent; 85 patients in group B by mixed iodine embolus agent (ultra-liquified iodinized oil + gelatin sponge + chemotherapeutic agents). The pattern of the arrested iodine deposition in the tumor, response, resectability during follow-up, pathological changes, survival and complications in the two groups were analyzed and compared.
RESULTSThe pattern of full-and-dense iodine deposition in the tumor and the response rate (CR + PR) were 59.2% and 32.0% in group A, 89.4% and 56.5% in group B. Surgical resection after TACE was possible in 5.8% (6/103) of group A versus 15.3% (13/85) of group B. Complete tumor necrosis was observed in 1.0% and 4.7% in groups A and B, respectively. 1-, 2- and 3-year actual survival rates were 57.7%, 42.8% and 8.4% in group A, and 79.8%, 55.3%, 38.5% in group B. The difference in results between the two groups was statistically significant, however, the incidence of complication in the two groups was similar.
CONCLUSIONTransarterial chemoembolization with mixed iodine emboli is more effective than with the routine iodine emboli in the treatment of bulky or nodular hepatocellular carcinoma rich in blood supply. Mixed iodine emboli is tolerable without increase in severe complications.
Antineoplastic Combined Chemotherapy Protocols ; therapeutic use ; Carcinoma, Hepatocellular ; therapy ; Catheters, Indwelling ; Chemoembolization, Therapeutic ; methods ; Ethiodized Oil ; administration & dosage ; Female ; Gelatin Sponge, Absorbable ; administration & dosage ; Hepatic Artery ; Humans ; Liver Neoplasms ; therapy ; Male
7.Transcatheter Arterial Embolization Using Ethanol in a Dialysis Patient for Contracting Enlarged Polycystic Kidneys.
Hark RIM ; Gyoo Sik JUNG ; Yeon Soon JUNG
Korean Journal of Radiology 2010;11(5):574-578
The mass effect of nephromegaly in patients with autosomal dominant polycystic kidney disease may cause pain and symptoms by compressing the alimentary tract, lungs, and heart. Conventional therapies exist to contract enlarged polycystic kidneys including surgical and interventional procedures. A surgical nephrectomy is often difficult to perform in dialysis patients due to the associated risks related to surgery. In contrast, renal transcatheter arterial embolization (TAE) with metallic coils, which is a less invasive interventional procedure, can also be utilized to contract enlarged kidneys in dialysis patients as an effective treatment. However, metallic coils present the possibility of recanalization and cost issues. Thus, we used ethanol instead of coils in renal TAE to resolve these issues. We report a dialysis patient with enlarged polycystic kidneys and poor oral intake due to abdominal distention that was successfully treated by TAE with absolute ethanol.
Aged
;
Contrast Media/administration & dosage
;
Embolization, Therapeutic/*methods
;
Ethanol/*therapeutic use
;
Ethiodized Oil/administration & dosage
;
Humans
;
Male
;
Polycystic Kidney, Autosomal Dominant/radiography/*therapy
;
*Renal Dialysis
;
Tomography, X-Ray Computed
8.Computed Tomography Guided Percutaneous Injection of a Mixture of Lipiodol and Methylene Blue in Rabbit Lungs: Evaluation of Localization Ability for Video-Assisted Thoracoscopic Surgery.
Kwang Nam JIN ; Kyung Won LEE ; Tae Jung KIM ; Yong Sub SONG ; Dong Il KIM
Journal of Korean Medical Science 2014;29(1):129-136
Preoperative localization is necessary prior to video assisted thoracoscopic surgery for the detection of small or deeply located lung nodules. We compared the localization ability of a mixture of lipiodol and methylene blue (MLM) (0.6 mL, 1:5) to methylene blue (0.5 mL) in rabbit lungs. CT-guided percutaneous injections were performed in 21 subjects with MLM and methylene blue. We measured the extent of staining on freshly excised lung and evaluated the subjective localization ability with 4 point scales at 6 and 24 hr after injections. For MLM, radio-opacity was evaluated on the fluoroscopy. We considered score 2 (acceptable) or 3 (excellent) as appropriate for localization. The staining extent of MLM was significantly smaller than methylene blue (0.6 vs 1.0 cm, P<0.001). MLM showed superior staining ability over methylene blue (2.8 vs 2.2, P=0.010). Excellent staining was achieved in 17 subjects (81%) with MLM and 8 (38%) with methylene blue (P=0.011). An acceptable or excellent radio-opacity of MLM was found in 13 subjects (62%). An appropriate localization rate of MLM was 100% with the use of the directly visible ability and radio-opacity of MLM. MLM provides a superior pulmonary localization ability over methylene blue.
Animals
;
Ethiodized Oil/*administration & dosage
;
Fluoroscopy
;
Injections, Subcutaneous
;
Lung/*radiography/surgery
;
Methylene Blue/*administration & dosage
;
Preoperative Care
;
Rabbits
;
Solitary Pulmonary Nodule/*surgery
;
Staining and Labeling/methods
;
Thoracic Surgery, Video-Assisted/*methods
;
Thoracoscopy/methods
;
Tomography, X-Ray Computed
9.Effects of transcatheter arterial chemoembolization with pingyangmycin-lipiodol emulsion on VX2 liver tumors in rabbits.
Xi LIU ; Xiao-ping LUO ; Wen-ting CAO ; Hao DENG
Chinese Journal of Hepatology 2012;20(8):611-616
To evaluate the changes induced in tumor tissue, the feeding artery, and neovascularization upon pingyangmycin-lipiodol emulsion treatment via transcatheter arterial chemoembolization (TACE) using the rabbit VX2 liver cancer model. The VX2 liver tumor model was established in 28 rabbits, and baseline tumor volume (V1, in mm3) was measured by spiral scan computed tomography (CT). Then, the rabbits were randomly divided into four groups (n = 7 each) and administered intraarterial therapies of: ultrafluid lipoidol embolization (group A); pingyangmycin (group B); pingyangmycin-lipiodol emulsion (group C); or saline (group D). All rabbits were sacrificed seven days later, and the response to therapy was determined by measuring the tumor volume (V2, in mm3), calculating the tumor growth rate, detecting expression of the vascular endothelial growth factor (VEGF) tumor biomarker, and performing histological analysis of the microvessel density (MVD) in the liver. Prior to therapy, the average V1 of the groups was statistically similar (A: 389.8+/-167.3, B: 404.1+/-184.9, C: 355.1+/-158.3, D: 378.1+/-189.0; (F = 0.257, P more than 0.05). In contrast, after therapy the average V2 of the groups was significantly different (A: 922.6+/-32.9, B: 665.9+/-99.9, C: 349.5+/-177.8, D: 1403.5+/-411.2; F = 26.23, P less than 0.05), as was the tumor growth ratio (A: 1.4, B: 0.6, C: -0.02, D: 2.7) and the mean positive ratio of VEGF (A: 57.1%, B: 42.9%, C: 28.6%, D: 100%; F = 8.407, P less than 0.05). MVD was highest in group D and lowest in group C (all, P less than 0.05). Bivariate correlation analysis revealed a positive correlation between VEGF expression and MVD (r = 0.743, P less than 0.01). Pingyangmycin exerts anti-tumor effects in the rabbit VX2 liver cancer model, but is more effective when administered as the combination therapy of pingyangmycin-lipiodol emulsion with TACE.
Animals
;
Antibiotics, Antineoplastic
;
administration & dosage
;
therapeutic use
;
Bleomycin
;
administration & dosage
;
analogs & derivatives
;
therapeutic use
;
Chemoembolization, Therapeutic
;
methods
;
Emulsions
;
Ethiodized Oil
;
administration & dosage
;
therapeutic use
;
Female
;
Iodized Oil
;
administration & dosage
;
therapeutic use
;
Liver Neoplasms, Experimental
;
blood supply
;
drug therapy
;
pathology
;
Male
;
Microvessels
;
Neoplasm Transplantation
;
Neovascularization, Pathologic
;
Rabbits
;
Random Allocation
;
Tumor Burden
;
drug effects
;
Vascular Endothelial Growth Factor A
;
metabolism
10.Does Establishing a Safety Margin Reduce Local Recurrence in Subsegmental Transarterial Chemoembolization for Small Nodular Hepatocellular Carcinomas?.
Hyo Jin KANG ; Young Il KIM ; Hyo Cheol KIM ; Hwan Jun JAE ; Saebeom HUR ; Jin Wook CHUNG
Korean Journal of Radiology 2015;16(5):1068-1078
OBJECTIVE: To test the hypothesis that a safety margin may affect local tumor recurrence (LTR) in subsegmental chemoembolization. MATERIALS AND METHODS: In 101 patients with 128 hepatocellular carcinoma (HCC) nodules (1-3 cm in size and < or = 3 in number), cone-beam CT-assisted subsegmental lipiodol chemoembolization was performed. Immediately thereafter, a non-contrast thin-section CT image was obtained to evaluate the presence or absence of intra-tumoral lipiodol uptake defect and safety margin. The effect of lipiodol uptake defect and safety margin on LTR was evaluated. Univariate and multivariate analyses were performed to indentify determinant factors of LTR. RESULTS: Of the 128 HCC nodules in 101 patients, 49 (38.3%) nodules in 40 patients showed LTR during follow-up period (median, 34.1 months). Cumulative 1- and 2-year LTR rates of nodules with lipiodol uptake defect (n = 27) and those without defect (n = 101) were 58.1% vs. 10.1% and 72.1% vs. 19.5%, respectively (p < 0.001). Among the 101 nodules without a defect, the 1- and 2-year cumulative LTR rates for nodules with complete safety margin (n = 52) and those with incomplete safety margin (n = 49) were 9.8% vs. 12.8% and 18.9% vs. 19.0% (p = 0.912). In multivariate analyses, ascites (p = 0.035), indistinct tumor margin on cone-beam CT (p = 0.039), heterogeneous lipiodol uptake (p = 0.023), and intra-tumoral lipiodol uptake defect (p < 0.001) were determinant factors of higher LTR. CONCLUSION: In lipiodol chemoembolization, the safety margin in completely lipiodolized nodule without defect will not affect LTR in small nodular HCCs.
Adult
;
Aged
;
Carcinoma, Hepatocellular/radiography/*therapy
;
Chemoembolization, Therapeutic
;
Cone-Beam Computed Tomography
;
Ethiodized Oil/*administration & dosage
;
Female
;
Follow-Up Studies
;
Humans
;
Liver Neoplasms/radiography/*therapy
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Neoplasm Recurrence, Local/radiography